Definium Therapeutics Inc. Common Shares vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.26 (market cap $39.95B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 8.5× Definium Therapeutics Inc. Common Shares's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.2% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days on average.
| DFTX | HLN | |
|---|---|---|
Market Cap | $4.71B | $39.95B |
Volume | 1,966,636 | 18,243,581 |
Sector | Health | Health |
52-Week High | $48.45 | $11.27 |
52-Week Low | $10.68 | $8.70 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $49.77B |
Dividend Yield | — | 2.2% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →